RET and cancer: Research in pancreatic cancer shows consistent overexpression of GDNF by both cancer and nerve cells, which acts through the Ret proto-oncogene (RET) receptor and GDNF family receptor (GFR) α1 to attract cancer cells to nerves [33,34].